KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$1.5 million.

  • Bionano Genomics' Change in Inventory fell 16160.13% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.3 million, marking a year-over-year decrease of 26292.83%. This contributed to the annual value of $587000.0 for FY2024, which is 8585.54% down from last year.
  • As of Q3 2025, Bionano Genomics' Change in Inventory stood at -$1.5 million, which was down 16160.13% from -$724000.0 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Change in Inventory ranged from a high of $6.7 million in Q3 2021 and a low of -$3.5 million during Q3 2023
  • Its 5-year average for Change in Inventory is $2.2 million, with a median of $1.6 million in 2023.
  • As far as peak fluctuations go, Bionano Genomics' Change in Inventory skyrocketed by 84770.8% in 2021, and later tumbled by 98640.48% in 2024.
  • Quarter analysis of 5 years shows Bionano Genomics' Change in Inventory stood at $5.6 million in 2021, then fell by 0.48% to $5.6 million in 2022, then tumbled by 94.04% to $331000.0 in 2023, then crashed by 986.4% to -$2.9 million in 2024, then skyrocketed by 48.6% to -$1.5 million in 2025.
  • Its last three reported values are -$1.5 million in Q3 2025, -$724000.0 for Q2 2025, and -$1.1 million during Q1 2025.